Clover Health Investments (CLOV) Reports Q2 results; offers guidance

Clover Health Investments (NASDAQ: CLOV) reported Q2 Revenue for the quarter at $477.62 million versus the consensus estimate of $468.3 million.

GUIDANCE:

Clover Health Investments sees FY2025 revenue of $1.8-1.875 billion, versus the consensus of $1.863 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Biogen expects $164M R&D charge to hit Q2 2026 earnings
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance